|
Alector, Inc. (ALEC) DCF -Bewertung
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Alector, Inc. (ALEC) Bundle
Gewinnen Sie mit unserem ausgefeilten DCF -Taschenrechner Einblick in Ihre Alector, Inc. (ALEC) -Schanganalyse! Diese Excel -Vorlage mit realen ALEC -Daten ermöglicht es Ihnen, Prognosen und Annahmen anzupassen, um den inneren Wert von Alector, Inc. genau zu bestimmen.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 21.1 | 207.1 | 133.6 | 97.1 | 100.6 | 110.8 | 122.1 | 134.5 | 148.3 | 163.4 |
| Revenue Growth, % | 0 | 881.54 | -35.48 | -27.36 | 3.6 | 10.19 | 10.19 | 10.19 | 10.19 | 10.19 |
| EBITDA | -187.9 | -29.0 | -129.4 | -142.9 | -145.0 | -91.0 | -100.3 | -110.6 | -121.8 | -134.2 |
| EBITDA, % | -890.65 | -14.03 | -96.82 | -147.22 | -144.19 | -82.17 | -82.17 | -82.17 | -82.17 | -82.17 |
| Depreciation | 7.3 | 8.3 | 8.5 | 8.8 | .0 | 11.9 | 13.2 | 14.5 | 16.0 | 17.6 |
| Depreciation, % | 34.43 | 4.02 | 6.34 | 9.12 | 0 | 10.78 | 10.78 | 10.78 | 10.78 | 10.78 |
| EBIT | -195.2 | -37.4 | -137.8 | -151.7 | -145.0 | -92.6 | -102.1 | -112.5 | -124.0 | -136.6 |
| EBIT, % | -925.08 | -18.04 | -103.16 | -156.33 | -144.19 | -83.61 | -83.61 | -83.61 | -83.61 | -83.61 |
| Total Cash | 413.3 | 735.3 | 712.9 | 548.9 | 413.4 | 110.8 | 122.1 | 134.5 | 148.3 | 163.4 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | 7.4 | 2.6 | .0 | .0 | 1.2 | 1.3 | 1.5 | 1.6 | 1.8 |
| Account Receivables, % | 0 | 3.57 | 1.94 | 0 | 0 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 |
| Inventories | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payable | 3.0 | 4.7 | 4.2 | 3.8 | 2.2 | 5.7 | 6.3 | 6.9 | 7.6 | 8.4 |
| Accounts Payable, % | 14.24 | 2.29 | 3.14 | 3.89 | 2.2 | 5.15 | 5.15 | 5.15 | 5.15 | 5.15 |
| Capital Expenditure | -5.0 | -3.2 | -4.1 | -2.4 | -1.3 | -7.1 | -7.9 | -8.7 | -9.5 | -10.5 |
| Capital Expenditure, % | -23.85 | -1.57 | -3.08 | -2.45 | -1.25 | -6.44 | -6.44 | -6.44 | -6.44 | -6.44 |
| Tax Rate, % | -0.10763 | -0.10763 | -0.10763 | -0.10763 | -0.10763 | -0.10763 | -0.10763 | -0.10763 | -0.10763 | -0.10763 |
| EBITAT | -187.7 | -28.8 | -141.3 | -158.1 | -145.2 | -87.7 | -96.6 | -106.5 | -117.3 | -129.3 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -182.5 | -29.4 | -132.7 | -149.4 | -148.0 | -80.6 | -90.9 | -100.1 | -110.3 | -121.6 |
| WACC, % | 6.26 | 6.1 | 6.3 | 6.3 | 6.3 | 6.25 | 6.25 | 6.25 | 6.25 | 6.25 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -416.2 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -124 | |||||||||
| Terminal Value | -2,918 | |||||||||
| Present Terminal Value | -2,155 | |||||||||
| Enterprise Value | -2,571 | |||||||||
| Net Debt | 9 | |||||||||
| Equity Value | -2,580 | |||||||||
| Diluted Shares Outstanding, MM | 97 | |||||||||
| Equity Value Per Share | -26.72 |
What You Will Get
- Editable Forecast Inputs: Easily modify assumptions (growth %, margins, WACC) to explore various scenarios.
- Real-World Data: Alector, Inc.’s (ALEC) financial data pre-loaded to kickstart your analysis.
- Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value for you.
- Customizable and Professional: A refined Excel model that tailors to your valuation requirements.
- Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.
Key Features
- Comprehensive DCF Calculator: Features detailed unlevered and levered DCF valuation models tailored for Alector, Inc. (ALEC).
- WACC Calculator: Ready-to-use Weighted Average Cost of Capital sheet with adjustable parameters.
- Customizable Forecast Assumptions: Adjust growth rates, capital expenditures, and discount rates as needed.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios specific to Alector, Inc. (ALEC).
- Visual Dashboard and Charts: Graphical representations summarize essential valuation metrics for straightforward analysis.
How It Works
- Step 1: Download the prebuilt Excel template featuring Alector, Inc.'s (ALEC) data.
- Step 2: Navigate through the pre-filled sheets to grasp the essential metrics.
- Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly see the recalibrated results, including Alector, Inc.'s (ALEC) intrinsic value.
- Step 5: Utilize the outputs to make informed investment choices or create reports.
Why Choose This Calculator for Alector, Inc. (ALEC)?
- Accuracy: Utilizes real Alector financial data to ensure precise calculations.
- Flexibility: Tailored for users to easily test and adjust inputs as needed.
- Time-Saving: Avoid the complexities of creating a DCF model from the ground up.
- Professional-Grade: Crafted with the expertise and usability expected at the CFO level.
- User-Friendly: Intuitive design makes it accessible for users without extensive financial modeling skills.
Who Should Use This Product?
- Professional Investors: Develop comprehensive and accurate valuation models for analyzing Alector, Inc. (ALEC) investments.
- Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
- Consultants and Advisors: Deliver precise valuation insights to clients regarding Alector, Inc. (ALEC) stock.
- Students and Educators: Utilize actual market data to enhance learning and practice in financial modeling.
- Biotech Enthusiasts: Gain insights into how biotech companies like Alector, Inc. (ALEC) are assessed in the financial market.
What the Template Contains
- Pre-Filled DCF Model: Alector, Inc.’s (ALEC) financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate Alector, Inc.’s (ALEC) profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.